Definitive half-year results 2024 of the EMS Group

On July 12, 2024, the EMS Group published its provisional half-year figures 2024. The definitive half-year figures 2024 are now available, based on the individual financial statements of the affiliated companies as at June 30, 2024. The Interim Financial Report 2024 shows no significant changes to the provisional report. 

The EMS Group achieved consolidated net sales amounting to CHF 1,087 million (1,183). While a significantly stronger Swiss Franc curtailed net sales development, the global sales offensive, launched in 2023, already delivered successful results with profitable new business in the first half of 2024. As a consequence, sales volumes, net operating income (EBIT) and net income exceeded the previous year's figures in a pleasing way. 

As expected, the global economic development was weak in the first half of 2024 and the consumer mood, in particular in the main markets Europe and China, remained depressed. Ongoing geopolitical conflicts are unsettling consumers and companies. Additionally, lower spending power is hampering the consumer mood. Switzerland's moderate inflation rates and its role as a "safe haven" strengthened the Swiss Franc. 

Due to its strong position with specialties and attractive innovations, EMS was able to achieve a net operating income (EBIT) of CHF 291 million (280) and a net operating income before depreciation (EBITDA) of CHF 319 million (305), despite a weak market environment and unfavorable foreign currencies. In this way, the EBIT was 4.2% above previous year, EBITDA 4.4%. The EBIT margin reached 26.8% (23.6%) and the EBITDA margin 29.4% (25.8%). 

Net financial income amounted to CHF -2 million (0). Net income for the first half of 2024 reached CHF 252 million (247), an increase of +2.1% compared to prior year. Equity attributable to the shareholders of the EMS-CHEMIE HOLDING AG increased to CHF 1,998 million (31.12.2023: CHF 1,742 million). The equity ratio was 82.7% (31.12.2023: 80.4%).